Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vera Therapeutics, Inc.

22.74
-0.8500-3.60%
Pre-market: 23.500.7600+3.34%04:53 EDT
Volume:874.40K
Turnover:19.44M
Market Cap:1.45B
PE:-8.27
High:22.94
Open:22.69
Low:21.23
Close:23.59
Loading ...

Positive Outlook for Vera Therapeutics: Buy Rating on Atacicept’s Potential in IgA Nephropathy

TIPRANKS
·
Yesterday

Vera Therapeutics completes enrollment in ORIGIN Phase 3 trial for atacicept

TIPRANKS
·
Yesterday

Vera Therapeutics Completes Full Enrollment in Pivotal ORIGIN Phase 3 Trial for Atacicept in IgAN

GlobeNewswire
·
Yesterday

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
12 Mar

Stock Track | Vera Therapeutics Soars 5.21% on Buy Rating and Price Target Increase from TD Cowen

Stock Track
·
06 Mar

Vera Therapeutics (VERA) Gets a Buy from TD Cowen

TIPRANKS
·
05 Mar

Vera Therapeutics Is Maintained at Overweight by JP Morgan

Dow Jones
·
05 Mar

Vera Therapeutics price target lowered to $71 from $77 at JPMorgan

TIPRANKS
·
04 Mar

Stock Track | Vera Therapeutics Soars 5.08% on Analyst Updates and Conference Participation

Stock Track
·
28 Feb

Vera Therapeutics Is Maintained at Buy by Guggenheim

Dow Jones
·
27 Feb

Wedbush Adjusts Price Target on Vera Therapeutics to $34 From $38, Maintains Neutral Rating

MT Newswires Live
·
27 Feb

Vera Therapeutics to Participate in the TD Cowen 45th Annual Health Care Conference

GlobeNewswire
·
27 Feb

Vera Therapeutics Inc : Raymond James Cuts Target Price to $73 From $76

THOMSON REUTERS
·
27 Feb

Vera Therapeutics Inc : Guggenheim Raises Target Price to $61 From $59

THOMSON REUTERS
·
27 Feb

Analysts Offer Insights on Healthcare Companies: Agilent (A) and Vera Therapeutics (VERA)

TIPRANKS
·
27 Feb

Optimistic Buy Rating for Vera Therapeutics: Strong Financials and Promising Pipeline Drive Positive Outlook

TIPRANKS
·
27 Feb

Earnings Flash (VERA) Vera Therapeutics Posts Full Year 2024 Total Operating Expenses $167.2M

MT Newswires Live
·
26 Feb

Vera Therapeutics FY 2024 GAAP EPS $(2.75) Beats $(2.83) Estimate

Benzinga
·
26 Feb

Earnings Flash (VERA) Vera Therapeutics Posts Full Year 2024 Net Loss $-2.75 a Share, vs. FactSet Est of $-2.90 Loss

MT Newswires Live
·
26 Feb

BRIEF-Vera Therapeutics FY EPS USD -2.75 Vs. IBES Estimate USD -2.84

Reuters
·
26 Feb